Hudson Bay Capital Management LP Rezolute, Inc. Transaction History
Hudson Bay Capital Management LP
- $25.3 Billion
- Q3 2025
A detailed history of Hudson Bay Capital Management LP transactions in Rezolute, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 125,000 shares of RZLT stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125,000
Previous 125,000
-0.0%
Holding current value
$1.24 Million
Previous $557,000
108.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RZLT
# of Institutions
120Shares Held
68.8MCall Options Held
904KPut Options Held
50.5K-
Federated Hermes, Inc. Pittsburgh, PA14MShares$139 Million0.25% of portfolio
-
Siren, L.L.C. New York, NY4.87MShares$48.3 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$43.7 Million0.0% of portfolio
-
Blackstone Inc New York, NY3.02MShares$30 Million0.13% of portfolio
-
Mangrove Partners New York, NY2.88MShares$28.6 Million3.44% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $385M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...